LEF1 and myelodysplastic syndrome: WT1-AS and LEF1-AS1 are antisense transcripts of two PCGs, WT1 (Wilms tumor 1) and LEF1 (lymphoid enhancer binding factor 1), which belong among the strongest candidate genes showing an association with the prognosis of MDS patients [20].